SARS2 was patented by Ralph Baric in 2018

We finished the last post with a question for the UNC lab: “Two of the 2018 viruses in their freezer were called 293 and HK3. They will both become the second most debated genome in human history, behind SARS2.” The hive mind called the internet has already delivered an answer.

Dr Ralph Baric (RB) in 2018 “had already generated SARS-like chimeras…called 293 and HK3…which are 20% different than epidemic strains.” Dr Peter Daszak even confirmed the ~20% hypothesis!

In 2015, Baric was looking for coronaviruses that were less than 25% different than epidemic strains. In November 2019, Daszak said Baric was still “identifying” these types of strains. Remember, SARS2 was 22% different than epidemic strains.

Also note the nearest known sample to SARS2 was RaTG13 at 4% different. But Baric had two bat viruses called “293” and “HK3,” that were ~2% closer to SARS2. Both of those samples were patented by Baric in 2018.

Let me repeat, Dr Ralph Baric of the University of North Carolina patented the SARS-CoV-2 genome in 2018!

No, the Chinese did not copy or steal Baric’s ‘obscure’ methods. Yes, we all know the about the ‘other’ patents in SARS2; like Moderna, CGG-CGG, David E. Martin, and immune evasion. This was a Baric patent for the individual genome now called SARS-CoV-2.

Mother nature has never seen SARS2, so Baric claimed a lab origin would only be “within the records of the Wuhan Institute of Virology,” but SARS2 was in the records of a US Government patent office.

What was 293 and HK3?

They are basically two pieces of the same patented genome, but only 2% different than SARS2. If HK3 was HKU3, then “293” was a typo. It was actually “BtCoV 279,” so we are now looking for HKU3 and BtCoV 279.

Both bat samples called HKU3 and BtCoV 279, along with ~25% diversity, made it into the final draft of DARPA Defuse (see below). Basically Baric wanted to inoculate wild Chinese bats with his patented 2018 genome; now called SARS-CoV-2.

Pete Lincoln noted Baric received a patent for Chimeric Coronavirus Spike Proteins on the exact same date (Feb 2018) he wrote the DARPA Defuse bid (Feb 2018).

Baric filed the 2015 patent the same year he was looking for 25% divergent strains, like SARS2. UNC received the official patent in 2018, so it was full steam ahead on a US government biodefense project like DARPA Defuse.

Baric’s patent with US government highlighted some interesting pieces! Let’s zoom in on the most important piece.

Your human eyes are looking at the SARS-CoV-2 genome, back in 2018. Notice HKU3 to the left (S1) and BtCoV 279 to the right (S2). They were switched up in another Daszak typo, but it doesn’t matter because these two combined pieces were less than 2% different than SARS2.

Baric aptly called this genome his “Chimera Mix,” which got mixed up in this biodefense project. Baric was a man who came from nothing to become something. He was the only person on the planet to create something from nothing. He could create a genome that was never seen in nature, but it was always sitting on a US government server.

The dirty biological details

In the above interview, Baric said he did not have access to Chinese viruses, but he could download Chinese sequences to ‘synthesize’ viruses in his UNC lab. He also had to start with a template, so the ‘novel’ Chimera Mix in Baric’s fridge included RaTG13 from China. Per the DARPA Defuse draft, Baric had access to WIV sequences.

RaTG13 was collected in 2013 by Dr Shi Zhengli and partially uploaded to NIAID’s database in 2018. Baric’s chimera also included the Laos Banal samples, collected by US Government in 2017, since its restriction sites aligned perfectly with SARS2.

Per the DARPA Defuse draft seen below, Baric did not want to “disturb the coding sequence” seen above.

When UNC published the SARS2 furin cleavage site (RRAR) in 2018, they also published the unique RSVAS amino acids of both Banal and RaTG13. UNC received SARS2-like sequences prior to the pandemic and was keeping this information from the public. Some find that secret “horrifying,” even though this information was in the public domain.

A popular theory for “293” sequences was the deadly Mojiang mineshaft (284 Alpha-CoVs + 9 Beta-CoVs = 293). Baric had referenced those “lethal human sequences” in his 2018 LAV bat vaccine paper. He also published the unique sequence motif (UGGUCGC) for Banal and RaTG13.

But ‘293’ was a typo by Daszak’s assistant, who conflated BtCoV 279 with “293-F cells,” during a busy DARPA teleconference. Once you see Baric’s BtCoV 279 and HKU3 chimera, you will never forget it.

Baric’s HKU3 was used for the 2008 consensus sequence paper. The consensus idea was prominent in DARPA Defuse and referenced by Dani and Linfa in 2019, so it was obvious this 2018 project was moving forward. Baric also created SARS2 to have “less than 5% nucleotide variation” to Laos Banal and RaTG13, so mission accomplished!

In 2010, Baric studied human coronavirus (HCoV-HKU1) and its HKU1b proteolytic cleavage sites using CGG-CGT codons; just one nucleotide off the infamous CGG-CGG furin cleavage site.

“Ralph’s Figure C” in the 2018 DARPA Defuse draft came from a 2016 HKU1 paper. The HKU1 furin cleavage site was extensively studied by the NIH ‘070 mRNA patent team. NIH, Scripps Institute, Moderna and UNC signed a joint contract in December 2019, so this story was much bigger than Baric.

FDA vaccine approval for humans takes 15-20 years, but it was just 2-5 years for animals. This bureaucratic loophole created a huge incentive for live bat research. Again, Baric’s safe humanized mice didn’t belch this “Chimera Mix” into the Wuhan air, but he will serve as a gateway of truth into a much bigger story.

Source

************